Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
There is a burgeoning epidemic of HIV among injection drug users in various countries in the Middle East and North Africa.
Recent advances in AIDS research have increased the hope of finding a functional, or therapeutic, cure for HIV.
Neither HIV infection nor its treatment appears to be associated with hearing loss, reported Tuesday, July 19, at the 6th IAS Conference
Antiretroviral drug regimens containing Norvir (ritonavir)-boosted Reyataz appear to work just as well for women, compared with men, in...
Truvada reduced new infections among men who have sex with men and transgender women by more than 90 percent
Could people coinfected with HIV and hepatitis C virus benefit from Selzentry (maraviroc)? Possibly, according to an important new study
The efficacy of Janssen Therapeutics’ Edurant (rilpivirine) is similar to that of Sustiva (efavirenz) over two years of treatment
Testing people for HIV during visits to hospital emergency departments in New Jersey has yielded the highest percentage of diagnoses of the in...
A new study shows that HIV-positive women are twice as likely to transmit the virus to a sexual partner if they use hormone-based birth contro...
Merck’s integrase inhibitor Isentress works as well as mainstay therapy efavirenz in HIV-positive individuals starting first time treatment
Encouraging preliminary results involving vaccine being developed by Maryland-based VIRxSYS Corporation were presented at 6th IAS Conference
Giovanni Alemanno, published an open letter to Silvio Berlusconi, urging the country to allocate funds to Global Fund to Fight AIDS
Gilead’s experimental once-daily integrase inhibitor elvitegravir works as well as Merck’s approved INI Isentress in treatment
Drugs known to penetrate the central nervous system do not appear to offer protection against neuropsychological problems with HIV infection
Genital secretions from women living with HIV using antiretroviral therapy contain high drug concentrations and low amounts of virus
ViiV Healthcare’s experimental integrase inhibitor dolutegravir was at least as effective as efavirenz (found in Sustiva and Atripla)
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.